Expression and relationship of PD-L1, CD24, and CD47 in hepatitis B virus associated hepatocellular carcinoma

Expression and relationship of PD-L1, CD24, and CD47 in hepatitis B virus associated hepatocellular carcinoma

Abstract Immune checkpoint inhibitor (ICI) therapy is the new standard treatment for advanced or metastatic hepatocellular carcinoma (HCC); however, many patients still fail to respond. This study explored the expression and prognosis of programmed death ligand 1 (PD-L1), cluster of differentiation...

Full description

Saved in:
Bibliographic Details
Main Authors: Aiping Lin, Mingxia Wang, Zhihui Wang, Juan Lin, Zhihui Lin, Shaowei Lin, Shiyun Lu, Hong Lin, Haijun Tang, Xueping Huang
Format: Article
Language:English
Published: Nature Portfolio 2024-12-01
Series:Scientific Reports
Subjects:
HBV-associated hepatocellular carcinoma
Immune checkpoint inhibitors
PD-L1
CD24
CD47
Online Access:https://doi.org/10.1038/s41598-024-83145-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items